Упрощенная HTML-версия
131
156.
Barbara J.A. Tumour necrosis factor-alpha (TNF-alpha): the good,
the bad and potentially very effective / J.A. Barbara, X. Van Ostade, A. Lopez //
Immunol Cell Biol. – 1996. – Vol. 74, N5. – P. 434-443.
157.
Barlow Y.T. Lymphocytes and immunosuppression in the burned
patient: a review / Y.T. Barlow // Burns. – 1994. – V.20, N6. – P. 487-490.
158.
Beyaert R. Molecular mechanisms of tumor necrosis factor-induced
cytotoxicity. What we do understand and what we do not / R. Beyaert, W. Fiers
// FEBS Lett. – 1994. – Vol. 340, N.1-2. – P. 9-16.
159.
Bistrian B.R. Acute phase proteins and the systemic inflammatory
response/ B.R. Bistrian // Crit. Care Med. -1999. – V. 27, N3. – P. 452-453.
160.
Blood hyperviscosity syndromes / G. Crepaldi, A. Calabro, M.
Belloni et al. // Ric. Clin. Lab. – 1983. – Vol. 13, № 3. – P. 89-104.
161.
Bone R. S. Immunologic dissonans: a continuihg evolution in our
understanding of the systemic inflammatory response syndrome (SIRS) and the
multiple organ dysfunction syndrome (MODS) / R.S. Bone // Ann. Int. Med. –
1996. – Vol.125, N 8. – P. 680-687.
162.
Bone R.C. Sepsis: a new hypothesis for pathogenesis of the disease
process/ R.C. Bone, C.J. Godzin, R.A. Balk// Chest. – 1997. – Vol.112. – P.
235-243.
163.
Bone R.C. Sir Isaac Newton, sepsis, SIRS and CARS// R.C. Bone//
Critical Care Medcin. – 1996. – Vol.24. – P. 1125-1129.
164.
Bookallil M. Challenges in preventing pyelonephritis in pregnant
women in indigenous communities/ M. Bookallil, E. Chalmers, B. Andrew//
Rural Remote Health. – 2005. – Vol.5, N3. – P. 395.
165.
Brumfitt W. New criteria for bacterial diagnosis and clinical
syndromes / W. Brumfitt // Diabetologia. – 1996. – N 3. – P 106/
166.
Busund R. Tumor necrosis factor and interleukin-1 appearance in
experimental Gram-negative septic shock/ R. Busund, R.O. Lindsetmo, I.T.
Rasmussen// J. Lab. Clin. Med. – 1990. – V.116. – P.100-105.